Recent Presentations
|
OMOP Presentations |
Download |
Statistical Methods for Drug Safety Surveillance by David Madigan |
December 7, 2011 |
|
Introduction to the OMOP Common Data Model Version 3.0 presented by Patrick Ryan and Lisa Schilling |
December 2, 2011 Slides Watch the Presentation on the OMOP site |
|
New Paradigms in Clinical Trial Methodology Symposium by David Madigan |
November 17, 2011 |
|
HIMSS Life Sciences Roundtable - Advancing the Science of Observational Data Analysis in Life Science by Marc Overhage |
November 16, 2011
Slides only Audio / Slides |
|
AcademyHealth Electronic Data Methods Forum Symposium- Opportunities for Standardized Observational Analytics to Support Causal Inference in Comparative Effectiveness Research by Patrick Ryan |
October 27, 2011 |
|
AMIA 2011 Annual Symposium - Design and Validation of a Data-simulation Model for Longitudinal Healthcare Data by Rich Murray and Patrick Ryan |
October 26, 2011 |
|
Query Health - “Summer Concert Series" on Distributed Population Queries. The Observational Medical Outcomes |
August 29, 2011 |
|
32nd Annual Conference of the International Society for Clinical Biostatistics (ISCB); Ottawa, Canada. Empirical Performance of Large-scale Analysis Methods for Active Surveillance: Lessons from the OMOP presented by Patrick Ryan |
August 25, 2011 |
|
ISPE 2011, 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. "Drug Induced Liver Injury: Latest Developments on Premarket Regulatory Guidance and Approaches to Postmarket Surveillance presented by Judy Racoosin |
August 16, 2011 |
|
ISPE 2011, 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. "Methods Development in Active Drug Safety Surveillance Highlighting the OMOP Findings presented by Abraham Hartzema, Patrick Ryan and Paul Stang |
|
|
2011 Joint Statistical Meetings. Bayesian Logistic Regression For Medical Claims Data Using CPU And GPU presented by Ivan Zorych |
|
|
DIA 2011 Annual Meeting. OMOP: Overview of Experimental Results presented by David Madigan |
|
|
Drug Safety Research Unit (DSRU) 6th Biennial Conference - Signal Detection and Interpretation in Pharmacovigilance, London, UK, presented by Patrick Ryan and David Madigan - June 2011 |
Click on each individual presentation to download |
|
OMOP Poster at the 3rd DEcIDE Methods Symposium 2011: Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research. OMOP Poster: An Empiric Exploration of Analytical Methods and Outcome Definitions for Patient Centered Outcomes Research |
FDA/PhRMA Biostatistics, Data Management, Scientific Programming Leaders Meeting, FDA, Rockville, MD |
Click on each individual presentation to download |
|
AcademyHealth, Electronic Data Methods Forum Symposium, Washington, DC: OMOP Results and Highlights presented by David Madigan |
|
|
International Society for Pharmacoepidemiology (ISPE) 2011 Mid-Year Meeting: OMOP Results and Perspectives presented by Patrick Ryan |
|
|
Brookings Roundtable: Highlights from the OMOP Symposium presented by Patrick Ryan |
|
|
Post-Market Safety Session of the 2nd Annual FDA / DIA Computational Science Meeting, Washington DC, Active Surveillance Methods Performance and Challenges: Lessons from OMOP presented by Patrick Ryan |
|
|
Pharmacovigilance and Risk Management Strategies 2011- DIA panel: Analysis for Health Care Data presented by Jonathan Morris, MD (UnitedBioSource) |
|
|
Pharmacovigilance and Risk Management Strategies 2011- DIA panel: Analysis for Health Care Data presented by Thomas Scarnecchia |
|
|
PRISM Forum Special Interest Group 2010 - Informatics Opportunities for Exploring the Real-World Effects of Medical Products: Lessons from the Observational Medical Outcomes Partnership presented by Patrick Ryan |
|
|
The Spotfire Life Science Forum 2010 - Visualization opportunities for systematic analyses of observational healthcare data: lessons from the Observational Medical Outcomes Partnership presented by Patrick Ryan |
|
|
Brookings Event - Methods for Signal Refinement in Active Medical Product Surveillance |
|
|
26th ICPE: International Conference on Pharmacoepidemiology & Therapeutic Risk Management - Implementing & Evaluating Standard Cohort Definitions, Steph Reisinger and Patrick Ryan |
|
|
OMOP Method Evaluation Discussion presented to the FDA by David Madigan and Patrick Ryan |
|
|
2010 Joint Statistical Meeting - The Role of Statistics and Opportunities for Statisticians in Active Drug Safety Surveillance presented by Patrick Ryan |
|
|
2010 Joint Statistical Meeting - OMOP Methods Development presented by David Madigan |
|
|
WorldPharma 2010 - OMOP Methods Overview & Insights presented by Abraham G. Hartzema |
|
|
Brookings Roundtable on Active Medical Product Surveillance - OMOP Methods Overview & Progress presented by David Madigan & Patrick Ryan |
|
|
46th Annual DIA Meeting 2010 - The Role of Statistics & Opportunities for Statisticians in Active Drug Safety Surveillance presented by Patrick Ryan |
|
|
46th Annual DIA Meeting 2010 - OMOP Overview & Progress presented by |
|
|
OMOP Extended Consortium Overview presented by Patrick Ryan |
April 22, 2010 |
|
ISPE Mid-Year Symposium - April 12, 2010 |
Click on each individual presentation to download |
|
OMOP: Overview of Methods Development and Evaluation Overview & Progress presented at the FDA |
|
|
OMOP Overview & Progress presented at the FDA |
|
|
DIA Conference on Signal Detection & Data Mining |
|
|
M2009 Data Mining Conference |
|
|
Institute of Medicine of the National Academies |
|
|
DIA Annual Meeting |
|
|
Midwest Biopharmaceutical Statistics Workshop |
Disclaimer - Privacy Policy - Terms of Use - Follow us: 